From the ∗Department of Nuclear Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
†Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
‡Fujian Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian Province, China
Received for publication September 12, 2022; revision accepted November 1, 2022.
Conflicts of interest and sources of funding: The authors declare that they have no conflict of interest. Funding information: This study was funded by Natural Science Foundation of Fujian Province (No. 2022J01683) (S.Z.), National Natural Science Foundation of China (No. 81971651) (W.M.), and Natural Science Foundation of Fujian Province (No. 2019J01454) (W.M.).
S.Z. and J.L. contributed equally to this work.
Compliance with ethical standards: The study was approved by the institutional review board of our hospital, and written informed consent for publication of this report was obtained from the patient.
Correspondence to: Weibing Miao, MD, PhD, Department of Nuclear Medicine, The First Affiliated Hospital of Fujian Medical University, No 20 Chazhong Road, Taijiang District, Fuzhou, Fujian, China 350005. E-mail: [email protected]; Xiangjin Chen, MD, PhD, Department of Thyroid and Breast Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China. E-mail: [email protected].
